Jing Wang is a Neurology physician. ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1459 Laney Walker Blvd
Augusta, GA 309120002
Telephone
706-721-7005Provider last certified this registry record 9 Jul 2024.
Clinical trials
- Effects of Blood Flow Restriction Training on Neuromuscular Function and Performance in Artistic Jump Rope Athletes
Sponsor: Shanghai University of Sport
- Post-market European & Asian Registry to Evaluate the Minos™ Stent-Graft and Delivery System in Abdominal Aortic Aneurysm Treatment
Sponsor: Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd
- European Multi-Centre Post-Market Registry on Thoracic Endovascular Arch Repair Using Castor™ and Cratos™
Sponsor: Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Averitas Pharma Inc.Program year20251 payment
- UCB, Inc.Program year20251 payment
- Otsuka America Pharmaceutical, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2023–2026 per NIH RePORTER. The latest:
- Targeting Sigma 1 receptor as a novel therapy for limiting neurovascular injury in ROP
Augusta University
FY2026$385,000R01EY035411 - Targeting Sigma 1 receptor as a novel therapy for limiting neurovascular injury in ROP
Augusta University
FY2025$385,000R01EY035411 - Targeting Sigma 1 receptor as a novel therapy for limiting neurovascular injury in ROP
Augusta University
FY2024$385,000R01EY035411
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”